NCT03745716 2025-03-18APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)Aprea TherapeuticsPhase 3 Completed154 enrolled 10 charts
NCT06267898 2024-02-20Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMMLEuropean Society for Blood and Marrow TransplantationCompleted222 enrolled